This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclearmedicine diagnostic procedures.
Multiparametric MRI (mpMRI) is a widely used approach for diagnosing patients with prostate cancer and reduces the need for invasive biopsies in approximately 30% of cases, Brembilla explained. The trial will eventually enroll 167 undiagnosed patients with suspected disease who have been referred for biopsies, Brembilla noted.
A new PET radiotracer shows promise for diagnosing triple-negative breast cancer, researchers at Fudan University Shanghai Cancer Center in China have reported. The study was published February 13 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
PET imaging using a newly developed radiotracer has identified different patterns of brain tau pathology over time in early-onset versus late-onset Alzheimer’s disease patients, according to a study published February 1 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
PET/CT imaging using gallium-68 (Ga-68) Fibroblast activation protein inhibitor (FAPI) radiotracer over F-18 FDG appears promising in women with invasive lobular carcinoma (ILC), according to a study published March 14 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
PET/MRI imaging shows promise in diagnosing fevers or inflammation of unknown origin and may have advantages over PET/CT, according to a study published January 3 in the European Journal of Radiology. Inflammation of unknown origin (IUO) is defined as prolonged and perplexing inflammation with temperatures below 38.3 °C.
Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Research suggests that the accumulation of these proteins is a continuous process that starts decades before the onset of symptoms.
Currently, the CMS bundles Medicare payments for PET radiotracers for diagnosingdisease as part of the packaged cost of imaging procedures in hospital outpatient settings. Mo-99 is the source material for Tc-99m, which is used in an estimated 40,000 nuclearmedicine diagnostic exams each day in the U.S.
A PET radiotracer for diagnosing Alzheimer’s disease may also be used to measure vascular brain changes in patients during PET/MRI scans, according to a study published December 7 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
TORONTO -- AuntMinnie.com spoke with cardiac PET imaging expert Krishna Patel, MD, from Mount Sinai in New York City, at the Society of NuclearMedicine and Molecular Imaging annual meeting. Women are 2.5 to three times more likely to suffer from INOCA and coronary artery microvascular disfunction than men.
An emerging PET/CT radiotracer may be more predictive of progressive pulmonary fibrosis in interstitial lung patients than F-18 FDG PET/CT, according to research presented June 8 at the 2024 Society of NuclearMedicine and Molecular Imaging Annual Meeting (SNMMI).
PET/CT imaging with F-18 sodium fluoride (NaF) is emerging as a sensitive tool for detecting early atherosclerosis, according to a presentation at the recent Society of NuclearMedicine and Molecular Imaging (SNMMI) annual meeting.
Up to 80% of women with the disease who respond to first-line chemotherapy relapse within 18 months, the authors explained. The group analyzed data from 47 patients diagnosed with advanced HGSOC who underwent pretreatment scans at their center between 2012 and 2020. The study was published February 19 in Cancers. DEED, Attribution 4.0
He was regarded as a receptive person who helped other doctors in the discussion of cases to reach diagnoses. Those who specialized -- particularly in CT, MRI, neuroimaging, and nuclearmedicine/PET -- earned more. Researchers warned that the COVID-19 vaccine was manifesting on imaging in ways that appeared to be disease.
A new PET radiotracer has the potential for visualizing responses in liver cancer patients undergoing immunotherapy, according to a study published December 12 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
PET/MRI scans have revealed immune system reactions after COVID-19 vaccines in children with cancer, according to a study published October 26 in the Journal of NuclearMedicine. Several studies have demonstrated that vaccine-related lymphadenopathy may confound disease assessment in oncology patients, the researchers added.
This is just the third year that RSNA has offered a dedicated track on nuclearmedicine and molecular imaging, with eight scientific sessions covering research in prostate cancer imaging, breast cancer, cardiovascular and pulmonary imaging, and more. Which approach is best in newly diagnosed breast cancer? 8:40 a.m. |
Coronary artery disease (CAD) is the leading cause of mortality in the U.S. In a cohort of 1,282 patients who underwent invasive coronary angiography for suspected disease, noninvasive PET MPI performed within six months identified large perfusion defects (>10% of the left ventricular myocardium) in 82% of the patients.
Middlebrooks' research interest consists of using ultrahigh-field, 7-tesla MRI to plot brain microstructure and develop surgical treatment of brain tumors, epilepsy, and neurodegenerative and movement disorders such as Parkinson's disease, essential tremor, and dystonia.
A recently developed PET radiotracer identified sources of pain in patients with complex regional pain syndrome (CRPS) and led to effective treatments, according to a study presented June 10 at the Society of NuclearMedicine and Molecular Imaging (SNMMI) annual meeting.
New research reveals that a novel PET perfusion radiotracer can diagnose coronary artery disease in obese patients with superior sensitivity and specificity compared to 99mTc-SPECT myocardial perfusion imaging.
Nuclearmedicine technology firm Positrigo of Zurich, Switzerland, has secured European market clearance for its dedicated brain PET system, NeuroLF. The company received U.S.
PSMA-PET/CT has the potential to be an effective alternative imaging approach for diagnosing patients with renal cell carcinoma (RCC), a type of kidney cancer, according to a study published May 23 in the Journal of NuclearMedicine.
Nuclearmedicine and the future of precise, personalised care in diagnosing and treating diseases. The post NuclearMedicine at the Centre of Radiology and Radiopharmaceuticals appeared first on Open Medscience.
F-18 florbetaben PET scans for diagnosing Alzheimer’s disease can be reduced from 20 minutes to five minutes without losing accuracy, according to a recent study. Nuclearmedicine physicians validated and rated each scan as either amyloid-positive or negative. The study was published November 21 in EJNMMI Research.
Nuclearmedicine is a form of specialty medicine that uses radioactive tracers to evaluate bodily functions and to diagnose and treat a wide range of health conditions. Nuclear scans produce images of the body’s anatomy that cannot be obtained as clearly or fully with other imaging techniques.
PET/CT imaging with a new gallium-68-based prostate cancer radiotracer shows promise for detecting recurrent metastatic disease, according to a study published February 20 in the Journal of NuclearMedicine. Images and caption courtesy of the Journal of NuclearMedicine.
Radiologists are medical doctors who specialize in interpreting imaging studies like X-rays, CT scans, MRIs, and ultrasounds to diagnose and guide treatment for various conditions. For patients, this means: Timely diagnoses: Faster access to critical information, reducing delays in treatment.
Currently, the CMS bundles Medicare payments for PET radiotracers for diagnosingdisease as part of the packaged cost of imaging procedures in hospital outpatient settings. Mo-99 is the source material for Tc-99m, which is used in an estimated 40,000 nuclearmedicine diagnostic exams each day in the U.S.
milla1cf Tue, 06/11/2024 - 18:41 June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis, a condition referred to as the “Alzheimer’s disease of the heart.” This research was presented at the 2024 Society of NuclearMedicine and Molecular Imaging Annual Meeting.
with the incidence of disease among African American men approximately 70% higher than in Caucasian men. vs. 33.3%), but African Americans were diagnosed with anemia at higher rates (100% vs. 16.7%, p = 0.018). Prostate cancer is the second leading cause of cancer-related death and the most common cancer diagnosis for men in the U.S.,
GE HealthCare introduced the MINItrace Magni at the Society of NuclearMedicine and Molecular Imaging annual meeting (SNMMI) annual meeting, a newly designed, small-footprint cyclotron for in-house production of commercial PET radiotracers. The system’s 21 cm digital detector offers a 1.6-times
Morphological markers on MRI help diagnose autism. Ultrasound model predicts liver disease progression. Bodien, et al, New England Journal of Medicine , August 14, 2024. Commercially Available Chest Radiograph AI Tools for Detecting Airspace Disease, Pneumothorax, and Pleural Effusion.
christine.book Mon, 06/26/2023 - 11:55 June 26, 2023 — A first-in-human evaluation of the novel theranostic pair 68Ga-DOTA-5G / 177Lu-DOTA-ABM-5G has confirmed its ability to successfully detect metastatic pancreatic cancer and visualize targeted treatment of the disease.
milla1cf Tue, 08/15/2023 - 16:28 August 15, 2023 — In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy. In general, PSMA PET/CT is indicated when intermediate or high-risk cancer has been found on biopsy.
milla1cf Fri, 02/09/2024 - 09:17 February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before clinical symptoms arise, according to research published in the February issue of The Journal of NuclearMedicine. It is a complex autoimmune disease characterized by chronic inflammation.
We can’t treat what we don’t see, which is why we require precise image quality to help diagnose, plan treatment for, and monitor disease,” explains Prof. Flavio Forrer , MD, PhD, Chairman of NuclearMedicine in the Division of Radiology and NuclearMedicine at Kantonsspital St. Gallen in Switzerland [vii].
But cancer in initially diagnosed IBC patients has already metastasized about 20 percent of the time, approximately doubling the percentage of other breast cancer patients. Positron Emission Tomography (a PET scan) uses nuclearmedicine to detect metabolic signals emitted by cancer cells.
In interviews at the Society of NuclearMedicine and Molecular Imaging (SNMMI) conference, researchers discussed the potential impact of ultra-high resolution brain positron emission tomography (PET) as well as emerging PET radiotracers for detecting coronary artery disease in obese patients and diagnosing clear cell renal cell carcinoma.
For the practice of precision care in molecular imaging and nuclearmedicine, this begins with the production of radioisotopes for use in diagnostic tracers, which are administered to patients, attach to specific biomarkers, and release radioactive emissions to provide clinicians detailed molecular information unique to each patient.
Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.
His accidental discovery forever changed medicine and it has been a key tool in diagnosing and treating injuries and diseases for 128 years.” The discovery also paved the way for the development of radiologic science modalities used today like computed tomography, mammography, nuclearmedicine, radiation therapy and many others.
Doctors use imaging tests to see inside a patient’s body and diagnose their illnesses and injuries. There are several types of imaging tests that physicians use to detect cancer in patients: X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound (US), NuclearMedicine, and Positron Emission Tomography (PET).
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content